Crab season delay hurts tri-county fishermen
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Semtech’s LoRa technology debuts in Ventura County, around the world
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: UCSB grad school will help tech managers innovate in digital age
The Central Coast has a growing reputation as a cool place for startups. But amid dozens of new ventures and talk of a tech-centric future looms the reality of growing a fully functional technology company. Listening to the earnings calls for AppFolio and MindBody, which recently had successful IPOs, you begin to realize just how Read More →
Goleta breast implant maker Sientra shakes up C-Suite
The writing was on the wall at Sientra. On Nov. 12, the company’s top executives took the fall. The embattled Goleta-based breast implant manufacturer cleaned house Thursday afternoon. Sientra founder and CEO Hani Zeini stepped down as CEO and he will be replaced by industry veteran Jeffrey Nugent. Nicholas Simon also resigned as chairman Read More →
LA, Long Beach port closures helped Port of Hueneme
The Port of Hueneme benefitted from recent closures at the Ports of Los Angeles and Long Beach, Port of Hueneme President Jess Herrera said. Closures at the ports snarled traffic of cargo ships and left dozens of cargo ships sitting for days as they waited to be unloaded. Herrera said some traffic from Los Read More →
FDA to review Amgen’s new kidney disease dug
Thousand Oaks-based biotech giant Amgen announced on Nov. 6 that the Food and Drug Administration will review a new treatment for patients with chronic kidney disease. The new drug, Etelcalcetide, works by suppressing the secretion of a parathyroid hormone. The drug is administered intravenously three times per week at the end of a dialysis session. Read More →
